TherapeuticsMD Inc (TXMD)

Q: When does TXMD report earnings?

TherapeuticsMD Inc (TXMD) is expected to report earnings on Nov 10, 2026.

Q: Does TXMD pay dividends?

TherapeuticsMD Inc (TXMD) does not currently pay a regular dividend.

Q: What is TXMD's market cap?

TherapeuticsMD Inc (TXMD) has a market capitalization of $19.79M with a current stock price of $1.74.

Official site

HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

$1.74

+0.03 (+1.75%)

Market Cap: $19.79M

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

42%(14/33)

Avg Surprise

-33.14%

Last 12 of 39 reported quarters

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Aug 11, 2026Reported Aug 11	$0.01	N/A	-	N/A	Beat	-	-	-80.0%
Mar 31, 2026Mar 26 Reported May 12, 2026Reported May 12	$0.00	$0.00	-	N/A	Beat	-	-	-100.0%
Dec 31, 2025Dec 25 Reported Mar 30, 2026Reported Mar 30	$0.00	$0.00	-	N/A	Beat	-	-	-100.0%
Sep 30, 2025Sep 25 Reported Nov 12, 2025Reported Nov 12	$0.00	$0.00	-	N/A	Beat	-	-	+100.0%
Jun 30, 2025Jun 25 Reported Aug 12, 2025Reported Aug 12	$0.05	$0.00	-	N/A	Beat	-	-	+152.9%
Mar 31, 2025Mar 25 Reported May 13, 2025Reported May 13	$0.02	N/A	-	N/A	Beat	-	-	+128.6%
Dec 31, 2024Dec 24 Reported Mar 27, 2025Reported Mar 27	$0.02	$0.04	-	-45.25%	Miss	0	0 1 30d	+127.4%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-0.05	$0.04	-	-232.00%	Miss	-	-	+83.5%
Jun 30, 2024Jun 24 Reported Aug 12, 2024Reported Aug 12	$-0.09	$0.03	-	-415.00%	Miss	-	-	+60.6%
Mar 31, 2024Mar 24 Reported May 10, 2024Reported May 10	$-0.08	$0.03	-	-355.33%	Miss	-	-	+68.1%
Dec 31, 2023Dec 23 Reported Mar 29, 2024Reported Mar 29	$-0.08	$-0.13	$-0.13 - $-0.13	+38.46%	Beat	0	0 1 30d	-101.0%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-0.32	$-0.05	$-0.05 - $-0.05	-540.00%	Miss	0	0 1 30d	+89.8%

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	15.55x
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	-6.64%	Operating Margin	-32.20%
ROE	-1.08%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	3.22x	Quick Ratio	3.22x
Trading Statistics
Beta	0.63	Avg Volume	19.09K
52-Week High	$2.95	52-Week Low	$1.29

Technical Indicators Dashboard

Moving Averages

SMA 10$1.79

SMA 20$1.85

SMA 50$2.01

SMA 200$2.10

EMA 10$1.79

EMA 20$1.85

EMA 50$1.95

EMA 200$1.97

MACD

Line: -0.07Signal: -0.07Hist: -0.00

ADX

ADX: 49.2+DI: 5.6-DI: 30.2

Aroon & PSAR

Aroon Up4.0

Aroon Down100.0

PSAR$1.82

Bollinger Bands

Upper Band$2.01

Lower Band$1.69

%B Position1743%(Upper)

Band Width0.17

RSI (14-Day)

Neutral

34.6

Momentum Oscillators

Stoch %K20.5

Stoch %D17.9

Williams %R-65.4

ROC (10d)-3.3%

Momentum-0.06

CCI (20d)-110.7

MFI (14d)30.9

Volatility Measures

ATR (14d)$0.07(4.3%)

StdDev (20d)0.08

Hist Vol33.4%(Moderate)

Volume Flow

VWAP$1.74

OBV9.7M

AD Line-3.6M

CMF (20d)-0.141

Volume Metrics

Avg Vol (20d)19.8K

Vol Ratio1.7x(High)

VWMA (20d)$1.85

Pivot Points

R3$1.89

R2$1.86

R1$1.78

Pivot Point$1.75

S1$1.67

S2$1.64

S3$1.56

Advanced Oscillators

TSI-33.37

Ultimate Osc47.6

KST-125.85

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$869,000	$724,000	$893,000	$784,000	$952,000	$393,000	$667,000	$547,000	$234,000	$313,000	$502,000	$-53,000
Cost of Revenue	$0	$0	$906,000	$0	$0	$0	N/A	$0	$0	$0	$637,000	$0
Gross Profit	$869,000	$724,000	$893,000	$784,000	$952,000	$393,000	$667,000	$547,000	$234,000	$313,000	$502,000	$-53,000

Operating Expenses	$1.69M	$1.45M	$2.85M	$1.65M	$1.65M	$1.67M	$1.71M	$1.68M	$3.02M	$1.46M	$2.11M	$1.72M
R&D	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
SG&A	$1.58M	$1.35M	$2.70M	$1.52M	$1.55M	$1.49M	$1.61M	$1.58M	$1.58M	$1.32M	$1.48M	$1.59M
Operating Income	$-816,000	$-723,000	$-1,962,000	$-862,000	$-695,000	$-1,281,000	$-1,047,000	$-1,134,000	$-2,789,000	$-1,142,000	$-1,611,000	$-1,773,000

Interest Income	$69,000	$41,000	$0	$534,000	$29,000	$29,000	$0	$275,000	$349,000	$0	$0	$0
Interest Expense	$0	$0	$0	$3,000	$0	$0	$0	$3,000	$5,000	$0	$0	$20,000
Income Before Tax	$164,000	$103,000	$-580,000	$50,000	$545,000	$-668,000	$83,000	$-567,000	$-1,050,000	$-809,000	$-1,584,000	$-1,434,000
Income Tax Expense	$0	$0	$32,000	$0	$0	$-32,000	$-31,000	$0	$0	$0	$-43,000	$0

Net Income	$155,000	$95,000	$-619,000	$152,000	$551,000	$-653,000	$252,000	$-609,000	$-1,090,000	$-734,000	$-883,000	$-3,378,000

EBITDA	$424,000	$387,000	$278,000	$-385,000	$828,000	$-448,000	$664,000	$-743,000	$-1,214,000	$-676,000	$-1,062,000	$-1,285,000
EBIT	$95,000	$62,000	$181,000	$-481,000	$516,000	$-697,000	$564,000	$-839,000	$-1,394,000	$-809,000	$-1,699,000	$-1,414,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about TXMD

News

TherapeuticsMD Inc. stock outperforms competitors on strong trading day

Shares of TherapeuticsMD Inc. (TXMD) rose 1.75% to $1.74 on Friday, outperforming some competitors despite a mixed trading session for the broader market. The NASDAQ Composite Index saw gains while the Dow Jones...

MarketWatch•Nov 6, 2026 12:30 PM ET11/6/26•Somewhat-Bullish

TherapeuticsMD, Inc. (TXMD) Seasonal returns chart - Yahoo Finance

This article from Yahoo Finance provides a seasonal returns chart for TherapeuticsMD, Inc. (TXMD), displaying the average monthly price return for the period between 2016 and 2026. The stock currently trades on NasdaqGS...

Yahoo Finance Singapore•Nov 6, 2026 2:52 AM ET11/6/26•Neutral

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors

Shares of TherapeuticsMD Inc. (TXMD) fell 6.04% on Thursday, closing at $1.71, as the broader market also experienced a downturn with the NASDAQ Composite and Dow Jones Industrial Average both declining. The company's...

MarketWatch•Nov 5, 2026 12:29 PM ET11/5/26•Bearish

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors

Shares of TherapeuticsMD Inc. (TXMD) fell 1.66% on Tuesday, closing at $1.78, in a mixed trading session for the broader stock market. The NASDAQ Composite rose while the Dow Jones Industrial Average declined....

MarketWatch•Nov 3, 2026 12:30 PM ET11/3/26•Bearish

TherapeuticsMD Inc. Advanced Charts | TXMD

This article provides advanced chart data and financial information for TherapeuticsMD Inc. (TXMD), including its current stock price, market performance, volume, market value...

Barron's•Nov 1, 2026 7:10 PM ET11/1/26•Somewhat-Bearish

TXMD Valuation and Fair Value

Forward P/E: 2.3x
EV/EBITDA: 15.6x
PEG: -0.7x
P/B: 0.7x

See GNG's fair value

TXMD Profitability: Margins, ROIC and FCF

Gross margin: 100.0%
Operating margin: -32.2%
Net margin: -6.6%
ROE: -1.1%

TXMD Competitors

Company	Ticker
Immutep Ltd ADR	IMMP
Nano X Imaging Ltd	NNOX
Entero Therapeutics, Inc.	ENTO
IGC Pharma, Inc.	IGC
Seres Therapeutics Inc	MCRB
Quoin Pharmaceuticals Ltd DRC	QNRX
Akari Therapeutics PLC	AKTX
Cocrystal Pharma Inc	COCP

Sector: Healthcare

TXMD Bull Case vs Bear Case

Bear case

TXMD has a -6.6% net profit margin.
TXMD beat EPS estimates in 12.5% of its last 8 reported quarters.
TXMD's quarterly revenue changed -8.7% year over year.

TXMD Earnings: Beat Rate and Next Report

Beat rate: 1 of 8 quarters (12.5%)
Average surprise: -261.9%

TXMD Earnings Date

TXMD reports Nov 10, 2026. The date is estimated.

TXMD ETF Holders

GNG tracks 4 ETFs that hold TXMD. The largest weights:

Dimensional U.S. Core Equity 2 ETF (DFAC), <0.01% of the fund
Fidelity OTC Portfolio (FOCPX), <0.01% of the fund
Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund

Open the ETF Stock Exposure tool for TXMD

See insider activity

Frequently Asked Questions About TXMD

When does TXMD report earnings?